Literature DB >> 1503675

No direct clinical relevance of the human leucocyte antigen (HLA) system in clozapine-induced agranulocytosis.

F H Claas1, P A Abbott, M D Witvliet, J D'Amaro, P M Barnes, P Krupp.   

Abstract

The clinical use of clozapine in psychiatry is restricted by the associated risk of agranulocytosis. This risk is significantly higher than that associated with conventional antipsychotic medications. In order to identify a possible parameter to detect susceptible individuals before treatment, 103 patients with a history of clozapine-induced granulocytopenia or agranulocytosis and 95 matched control patients were typed for human leucocyte antigen (HLA)-A, -B, -C, -DR, -DQ and for a number of neutrophil-specific alloantigens. No significant association between certain HLA alleles or neutrophil antigens and susceptibility to clozapine-induced granulocytopenia or agranulocytosis was observed.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1503675     DOI： 10.2165/00002018-199200071-00004

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


  9 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  The estimation and significance of the logarithm of a ratio of frequencies.

Authors:  J B HALDANE
Journal:  Ann Hum Genet       Date:  1956-05       Impact factor: 1.670

Review 3.  Drug-induced agranulocytosis: review of possible mechanisms, and prospects for clozapine studies.

Authors:  F H Claas
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 4.  Leponex--associated granulocytopenia: a review of the situation.

Authors:  P Krupp; P Barnes
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia.

Authors:  J A Lieberman; J Yunis; E Egea; R T Canoso; J M Kane; E J Yunis
Journal:  Arch Gen Psychiatry       Date:  1990-10

6.  Levamisole-induced adverse reactions in HLA B27-positive rheumatoid arthritis.

Authors:  E M Veys; H Mielants; G Verbruggen
Journal:  Lancet       Date:  1978-01-21       Impact factor: 79.321

Review 7.  The interaction of drugs and endogeneous substances with HLA class-I antigens.

Authors:  F H Claas; J J van Rood
Journal:  Prog Allergy       Date:  1985

8.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

9.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11
  9 in total
  10 in total

Review 1.  Clinical profile of clozapine: adverse reactions and agranulocytosis.

Authors:  J A Lieberman; A Z Safferman
Journal:  Psychiatr Q       Date:  1992

2.  Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.

Authors:  Robert L Smith; Tore Haslemo; Ole A Andreassen; Erik Eliasson; Marja-Liisa Dahl; Olav Spigset; Espen Molden
Journal:  CNS Drugs       Date:  2017-11       Impact factor: 5.749

Review 3.  Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.

Authors:  Eromona Whiskey; David Taylor
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 4.  More than 25 years of genetic studies of clozapine-induced agranulocytosis.

Authors:  S A J de With; S L Pulit; W G Staal; R S Kahn; R A Ophoff
Journal:  Pharmacogenomics J       Date:  2017-04-18       Impact factor: 3.550

5.  Does eosinophilia predict clozapine induced neutropenia?

Authors:  M Hummer; B Sperner-Unterweger; G Kemmler; M Falk; M Kurz; H Oberbauer; W W Fleischhacker
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

6.  Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development.

Authors:  M Pirmohamed; K Park
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

7.  Acute agranulocytosis after prolonged high-dose usage of intravenous dipyrone--a different mechanism of dipyrone toxicity?

Authors:  J Sabbaga; C Osawa; F H Pahl; E Vellutini; D Pereira; I Cecconello
Journal:  Ann Hematol       Date:  1993-03       Impact factor: 3.673

Review 8.  Pharmacogenetics of antipsychotics: recent progress and methodological issues.

Authors:  Jian-Ping Zhang; Anil K Malhotra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-12-01       Impact factor: 4.481

Review 9.  Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis.

Authors:  Shusuke Numata; Hidehiro Umehara; Tetsuro Ohmori; Ryota Hashimoto
Journal:  Front Pharmacol       Date:  2018-09-26       Impact factor: 5.810

10.  Late Onset Agranulocytosis with Clozapine Associated with HLA DR4 Responding to Treatment with Granulocyte Colony-stimulating Factor: A Case Report and Review of Literature.

Authors:  Aakanksha Singh; Sandeep Grover; Pankaj Malhotra; Subhash C Varma
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-05-31       Impact factor: 2.582
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.